Wee Kim Wee School of Communication and Information, Nanyang Technological University, Singapore.
Department of Communications and New Media, National University of Singapore, Singapore.
Patient Educ Couns. 2022 Feb;105(2):277-283. doi: 10.1016/j.pec.2021.09.023. Epub 2021 Sep 20.
This study aims to investigate factors influencing COVID-19 vaccination intention in the United States.
A cross-sectional survey was conducted with 800 respondents recruited from an online panel managed by a survey company. Path analysis was employed to examine the relationships between the study variables.
First, perceived susceptibility to COVID-19 vaccine side effects was negatively associated with vaccination intention whereas perceived severity did not show any significant impact. Second, vaccine-related knowledge was not directly related to vaccination intention, but it had an indirect and positive effect on vaccination intention via decreasing perceived susceptibility. Third, doctor-patient communication strengthened the negative effect of vaccine knowledge on perceived susceptibility and severity.
The results of this study offer insights on how to increase people's vaccination intention and reduce their psychological concerns when making COVID-19 vaccine-related decisions.
Government agencies should actively promote the effectiveness and importance of vaccination, while addressing concerns about vaccine safety in the public; Health initiatives also need to enhance the level of knowledge about COVID-19 vaccines through various media channels; Doctors can start the conversations about COVID-19 vaccination with their patients at the point of care and/or via online communication platforms.
本研究旨在调查影响美国 COVID-19 疫苗接种意愿的因素。
采用横断面调查,从一家调查公司管理的在线小组中招募了 800 名受访者。采用路径分析来检验研究变量之间的关系。
首先,对 COVID-19 疫苗副作用的感知易感性与接种意愿呈负相关,而感知严重性则没有显示出任何显著影响。其次,疫苗相关知识与接种意愿没有直接关系,但通过降低感知易感性,对接种意愿有间接的积极影响。第三,医患沟通加强了疫苗知识对感知易感性和严重性的负面影响。
本研究结果提供了如何提高人们的接种意愿并在做出 COVID-19 疫苗相关决策时减轻他们心理担忧的见解。
政府机构应积极宣传疫苗接种的有效性和重要性,同时解决公众对疫苗安全性的担忧;健康倡议也需要通过各种媒体渠道提高对 COVID-19 疫苗的知识水平;医生可以在就诊时或通过在线沟通平台与患者开始讨论 COVID-19 疫苗接种。